Literature DB >> 21828184

Progesterone and Nestorone facilitate axon remyelination: a role for progesterone receptors.

Rashad Hussain1, Martine El-Etr, Ouardia Gaci, Jennifer Rakotomamonjy, Wendy B Macklin, Narender Kumar, Regine Sitruk-Ware, Michael Schumacher, Abdel M Ghoumari.   

Abstract

Enhancing the endogenous capacity of myelin repair is a major therapeutic challenge in demyelinating diseases such as multiple sclerosis. We found that progesterone and the synthetic 19-norprogesterone derivative 16-methylene-17α-acetoxy-19-norpregn-4-ene-3,20-dione (Nestorone) promote the remyelination of axons by oligodendrocytes after lysolecithin-induced demyelination in organotypic cultures of cerebellar slices taken from postnatal rats or mice. The intracellular progesterone receptors (PR) mediate the proremyelinating actions of Nestorone, because they are not observed in slices from PR knockout mice. Notably, Nestorone was less efficient in heterozygous mice, expressing reduced levels of PR, suggesting PR haploinsufficiency in myelin repair. Using mice expressing the enhanced green fluorescent protein (EGFP) under the control of the proteolipid gene promoter, we showed that both progesterone and Nestorone strongly increased the reappearance of cells of the oligodendroglial lineage in the demyelinated slices. In contrast to Nestorone, the pregnane derivative medroxyprogesterone acetate had no effect. The increase in oligodendroglial cells by Nestorone resulted from enhanced NG2(+) and Olig2(+) oligodendrocyte progenitor cell (OPC) recruitment. In cocultures of lysolecithin-demyelinated cerebellar slices from wild-type mice apposed to brain stem slices of proteolipid gene promoter-EGFP mice, Nestorone stimulated the migration of OPC towards demyelinated axons. In this coculture paradigm, Nestorone indeed markedly increased the number of EGFP(+) cells migrating into the demyelinated cerebellar slices. Our results show that Nestorone stimulates the recruitment and maturation of OPC, two steps which are limiting for efficient myelin repair. They may thus open new perspectives for the use of progestins, which selectively target PR, to promote the endogenous regeneration of myelin.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21828184      PMCID: PMC6285137          DOI: 10.1210/en.2011-1219

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  55 in total

1.  Lysolecithin induces demyelination in vitro in a cerebellar slice culture system.

Authors:  Eric Birgbauer; Tadimeti S Rao; Michael Webb
Journal:  J Neurosci Res       Date:  2004-10-15       Impact factor: 4.164

2.  A novel LacZ reporter mouse reveals complex regulation of the progesterone receptor promoter during mammary gland development.

Authors:  Preeti M Ismail; Jie Li; Francesco J DeMayo; Bert W O'Malley; John P Lydon
Journal:  Mol Endocrinol       Date:  2002-11

3.  Proteolipid promoter activity distinguishes two populations of NG2-positive cells throughout neonatal cortical development.

Authors:  Barbara S Mallon; H Elizabeth Shick; Grahame J Kidd; Wendy B Macklin
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

4.  Nestorone: a progestin with a unique pharmacological profile.

Authors:  N Kumar; S S Koide; Y Tsong; K Sundaram
Journal:  Steroids       Date:  2000 Oct-Nov       Impact factor: 2.668

Review 5.  Nestorone: clinical applications for contraception and HRT.

Authors:  Regine Sitruk-Ware; Margaret Small; Narender Kumar; Yun-Yen Tsong; Kalyan Sundaram; Theodore Jackanicz
Journal:  Steroids       Date:  2003-11       Impact factor: 2.668

6.  Progesterone and its metabolites increase myelin basic protein expression in organotypic slice cultures of rat cerebellum.

Authors:  A M Ghoumari; C Ibanez; M El-Etr; P Leclerc; B Eychenne; B W O'Malley; E E Baulieu; M Schumacher
Journal:  J Neurochem       Date:  2003-08       Impact factor: 5.372

7.  The Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple Sclerosis (POPART'MUS) trial: rationale, objectives and state of advancement.

Authors:  S Vukusic; I Ionescu; M El-Etr; M Schumacher; E E Baulieu; C Cornu; C Confavreux
Journal:  J Neurol Sci       Date:  2009-09-15       Impact factor: 3.181

8.  Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation.

Authors:  Gareth R John; Sai Latha Shankar; Bridget Shafit-Zagardo; Aldo Massimi; Sunhee C Lee; Cedric S Raine; Celia F Brosnan
Journal:  Nat Med       Date:  2002-09-23       Impact factor: 53.440

9.  Progesterone synthesis and myelin formation by Schwann cells.

Authors:  H L Koenig; M Schumacher; B Ferzaz; A N Thi; A Ressouches; R Guennoun; I Jung-Testas; P Robel; Y Akwa; E E Baulieu
Journal:  Science       Date:  1995-06-09       Impact factor: 47.728

10.  Estrogen-inducible progesterone receptor in primary cultures of rat glial cells.

Authors:  I Jung-Testas; J M Renoir; J M Gasc; E E Baulieu
Journal:  Exp Cell Res       Date:  1991-03       Impact factor: 3.905

View more
  29 in total

Review 1.  Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis.

Authors:  Dionne P Robinson; Sabra L Klein
Journal:  Horm Behav       Date:  2012-03-03       Impact factor: 3.587

Review 2.  Non-clinical studies of progesterone.

Authors:  R Sitruk-Ware
Journal:  Climacteric       Date:  2018-05-23       Impact factor: 3.005

3.  Nestorone® as a Novel Progestin for Nonoral Contraception: Structure-Activity Relationships and Brain Metabolism Studies.

Authors:  Narender Kumar; Jerôme Fagart; Philippe Liere; Scott J Mitchell; Alanah R Knibb; Isabelle Petit-Topin; Marion Rame; Martine El-Etr; Michael Schumacher; Jeremy J Lambert; Marie-Edith Rafestin-Oblin; Regine Sitruk-Ware
Journal:  Endocrinology       Date:  2017-01-01       Impact factor: 4.736

Review 4.  Contraception technology: past, present and future.

Authors:  Regine Sitruk-Ware; Anita Nath; Daniel R Mishell
Journal:  Contraception       Date:  2012-09-17       Impact factor: 3.375

5.  Progesterone receptors: a key for neuroprotection in experimental stroke.

Authors:  Ailing Liu; Isabelle Margaill; Shaodong Zhang; Florencia Labombarda; Bérard Coqueran; Brigitte Delespierre; Philippe Liere; Catherine Marchand-Leroux; Bert W O'Malley; John P Lydon; Alejandro F De Nicola; Regine Sitruk-Ware; Claudia Mattern; Michel Plotkine; Michael Schumacher; Rachida Guennoun
Journal:  Endocrinology       Date:  2012-05-25       Impact factor: 4.736

6.  Demyelination-Induced Inflammation Attracts Newly Born Neurons to the White Matter.

Authors:  Samah Kalakh; Abdeslam Mouihate
Journal:  Mol Neurobiol       Date:  2016-09-23       Impact factor: 5.590

7.  Progesterone and nestorone promote myelin regeneration in chronic demyelinating lesions of corpus callosum and cerebral cortex.

Authors:  Martine El-Etr; Marion Rame; Celine Boucher; Abdel M Ghoumari; Narender Kumar; Philippe Liere; Antoine Pianos; Michael Schumacher; Regine Sitruk-Ware
Journal:  Glia       Date:  2014-08-04       Impact factor: 7.452

8.  Differential effects of synthetic progestagens on neuron survival and estrogen neuroprotection in cultured neurons.

Authors:  Anusha Jayaraman; Christian J Pike
Journal:  Mol Cell Endocrinol       Date:  2014-01-11       Impact factor: 4.102

9.  Organotypic slice cultures to study oligodendrocyte dynamics and myelination.

Authors:  Robert A Hill; Jelena Medved; Kiran D Patel; Akiko Nishiyama
Journal:  J Vis Exp       Date:  2014-08-25       Impact factor: 1.355

Review 10.  Remyelination and multiple sclerosis: therapeutic approaches and challenges.

Authors:  Meredith D Hartley; Ghadah Altowaijri; Dennis Bourdette
Journal:  Curr Neurol Neurosci Rep       Date:  2014-10       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.